When the Science for Africa Foundation (SFA Foundation) appointed Dr. Evelyn Gitau as Chief Scientific Officer effective April 1, 2024, it marked more than a leadership transition. It signaled a bold strategic pivot.
The Foundation’s five-year agenda, From Science to Impact, is designed to push African research beyond laboratories and into commercial solutions, scalable ventures, stronger institutions, and policy-shaping evidence.
In boardrooms across the continent, the question is changing. It is no longer “How much research are we funding?” but “How much economic value is that research creating?”
CEO Prof. Tom Kariuki described the appointment as entrusting a “beacon of innovation and progress,” a leader expected to turn scientific output into measurable growth opportunities.
Reorganizing for Competitive Advantage
The Foundation recently realigned its programs around three economic engines:
- Health
- Climate and Environment
- Agriculture
These are not academic categories. They are trillion-dollar markets shaping jobs, trade balances, risk exposure, and industrial capability.
By structuring investment pipelines around these areas, the Foundation is positioning African research as a strategic asset, one that can drive partnerships, attract international capital, and scale local manufacturing capability.
This is science with a balance sheet.
The Leader Behind the Strategy
Dr. Gitau brings nearly two decades of medical research and close to a decade of senior leadership experience from the African Population and Health Research Center.
Her skillset bridges three worlds:
- rigorous research
- program execution at scale
- leadership of multidisciplinary teams
She has worked across implementation science, impact evaluation, cellular immunology, proteomics, genomics, and infectious diseases. More importantly, she has guided programs that translate scientific discovery into health outcomes, market opportunities, and institutional capacity.
For an organization managing complex portfolios across multiple countries, that combination is rare and valuable.
From Knowledge to Economic Value
In today’s Africa, research funding alone is not the win.
The win is when science:
- reduces health-care spending
- improves productivity
- drives locally manufactured solutions
- informs smarter regulation
- opens new export categories
Dr. Gitau understands this equation clearly. She argues that African scientists must sit inside development strategy conversations, not on the sidelines. Evidence should shape investment decisions, infrastructure choices, and market innovation, not arrive after policies are already decided.
That philosophy fits squarely within how investors, governments, and development partners now evaluate impact.
A Vision Anchored in Outcomes
As Chief Scientific Officer, Dr. Gitau wants to champion science that stretches knowledge while moving markets forward.
Her focus is on programs that produce tangible solutions to real issues: disease resilience, climate adaptation, agricultural productivity, and innovation-ready institutions.
The Foundation, under her direction, is evolving from a grant-making body into an innovation orchestrator, curating partnerships, identifying scalable opportunities, and supporting African institutions to own more of the value chain.
Building the Talent Pipeline Africa Needs
No business ecosystem survives without strong leadership pipelines. Dr. Gitau has long believed that Africa’s next economic gains will come from its scientists, if they are mentored, supported, and equipped to lead.
She has spent years developing young researchers, teaching them not only technical mastery, but also policy engagement, proposal development, and collaboration.
Each trained scientist becomes a multiplier: founding labs, leading programs, influencing policies, or launching ventures. That compounding effect creates stability and competitive advantage across sectors.
Why CEOs and Investors Should Pay Attention
For businesses operating in Africa, or entering African markets, the appointment matters.
Research strength feeds:
- pharmaceutical and biotech manufacturing
- climate-tech and agri-tech startups
- digital health platforms
- risk analytics and insurance modeling
- better supply-chain intelligence
When science ecosystems mature, private investment becomes less speculative and more strategic. Partnerships grow easier. Risk perceptions decrease. Market timelines shorten.
With Dr. Gitau steering scientific direction, the SFA Foundation becomes an anchor partner for organizations seeking credible pathways into Africa’s innovation landscape.
Execution Meets Strategy
Her leadership arrives as global funding priorities, technology cycles, and geopolitical trends converge. Institutions that thrive will be those capable of turning evidence into policy, industry collaboration, entrepreneurial ventures, and long-term competitiveness.
Dr. Gitau brings a disciplined, outcome-driven style. She values structure, measurable progress, and long-term systems building, traits essential in environments where programs cut across governments, academia, private sector, and communities.
The Future Being Built
Under this direction, African science will increasingly be evaluated on its ability to:
- commercialize discoveries
- strengthen domestic industries
- drive smarter regulation
- improve social outcomes
- attract international partnerships
That is not mission drift. It is mission maturity.
And as African economies push toward self-reliance, leaders like Dr. Evelyn Gitau will define what it means to turn knowledge into growth.
Her appointment represents intent. Her execution will shape outcomes. For the Science for Africa Foundation, it is a strategic investment. For Africa’s innovation economy, it marks an inflection point.
